Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Camcolit (lithium carbonate) Treatment Report
What is Camcolit?

Camcolit is an international brand name for lithium carbonate is used to treat and prevent episodes of mania in people with bipolar disorder (manic depressive disorder). Lithium is in a class of medications called antimanic agents, which work by decreasing abnormal activity in the brain. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my ALS progress 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 100%
None
0 0%

Most commonly reported side effects

Nausea
1 100%
Fatigue
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  400 mg daily
  1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Camcolit (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 100% Doctor's advice: 100%

See all 1 patient who’ve stopped taking Camcolit

Stopped Taking Camcolit

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 100%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Research:
Lithium & ALS

See how ALS patients taking lithium are doing in real-time by viewing FRS scores before and after starting lithium. Easily compare individual dosages and blood levels, and filter results by a rich set of patient characteristics.

Icon_bullet_arrow Research: Lithium & ALS

Report created on November 21, 2009.